Characteristics of Patients With Early-Onset Arthritis in Latin America: Description of the REPANARC Cohort

Ramagli A1, Corbacho ILinhares Fde Abreu PTeijeiro RGarau MDapueto JPan-American League for Rheumatology Early Onset Arthritis (PANLAR-EOA) Study Group.

Collaborators (29)

Author information

Abstract

BACKGROUND:

While many studies have tried to show that early intervention improves the clinical outcomes of early-onset arthritis, only a few were carried out in Latin America.

OBJECTIVES:

The aim of this study was to describe the Pan-American Registry of Early-Onset Arthritis (REPANARC) project and report the preliminary outcomes of a cohort of patients.

METHODS:

The REPANARC cohort consisted of a sample of patients from 6 Latin American countries. Patients with arthritis of 1 or more joints of 1-year duration or less were assessed by a rheumatologist during 6 consecutive clinical visits for a follow-up period of 2 years. The registry included clinical characteristics, medical history, physical examination, disease activity, analytical chemistries, imaging, current treatment, and a set of patient-reported outcome measures evaluating disability, psychological distress, and quality of life.

RESULTS:

A total of 173 patients were included with mean age of 41.9 ± 13.2 years; 83.8% were women. The predominant presentations at onset were insidious, polyarticular, additive, bilateral, and symmetrical. The initial diagnoses were rheumatoid arthritis (50.6%), undifferentiated arthritis (40.5%), and other arthritis (8.9%). With Disease Activity Score in 28 Joints, 76.9% had moderate to high disease activity, and 61.9% had moderate to severe disability (Health Assessment Questionnaire). Considering undifferentiated arthritis, 60.3% persisted undifferentiated, 29.4% evolved as rheumatoid arthritis, 4.4% remained self-limited, and 5.9% to other forms. The frequencies of depression and anxiety were high as measured with the Hospital Anxiety and Depression Scale, and approximately 20% had significant decrements in quality of life measured with the Medical Outcomes Study Short-Form 36 Health Survey Version 2. Mean time from the first symptoms to the first visit to a rheumatologist was 126 days. Shorter delays were confirmed to be associated with better outcomes.

CONCLUSIONS:

The REPANARC project is a useful tool to provide valuable information regarding patients with early-onset arthritis attending rheumatology centers in Latin-America.

PMID:

26308347

[PubMed – in process]

Comments Back to blog

Recommended articles Back to blog

Full grants offered to the ACR 2017

The term to apply for one of the 6 full grants offered by PANLAR to the American College of Rheumatology Annual...

panlar org

Call for exchange program PANLAR-ACR 2017

The ACR is pleased to collaborate with the Pan American League of Rheumatology Associations (PANLAR) to offer...

panlar org

These are the winners to the ACR 2016

We thank all the people who applied for this great call and congratulate the six beneficiaries who will accompany...

panlar org